Myriad Genetics Stock Guidance | NASDAQ:MYGN

Comments

Myriad Genetics Inc Stock Guidance

MYGNNASDAQ

Trade with Public

$4.75

0.163.49%

At close: Apr 2, 5:00 PM EST

$4.75

N/A

After Hours: 4:00 PM EST

Overview News Earnings OptionsGuidanceAnalyst Ratings Insider Trades Short Interest Stock Report

Myriad Genetics (MYGN) last issued guidance on February 23, 2026 for Q1 2026. The company guided revenue in the range of $200.00M - $203.00M for the period.

Compared to prior guidance, Myriad Genetics lowered its revenue forecast from a prior range of $860.00M - $880.00M.

Myriad Genetics has issued 28 guidance updates between May 5, 2022 and February 23, 2026. During this period, the company raised its outlook 7 times and lowered it 9 times, providing investors with insight into management's evolving expectations.

Latest Guidance Date

Feb 23, 2026

Guidance Period

Q1 2026

Revenue Guidance Range

$200.00M - $203.00M

Myriad Genetics Guidance History

Review all historical guidance issued by Myriad Genetics, including EPS and revenue forecasts across quarterly and annual periods.

Loading calendar...

FAQ

What is the most recent guidance for Myriad Genetics (MYGN)?

The most recent guidance for Myriad Genetics (MYGN) was reported on February 23, 2026 for Q1 2026. Myriad Genetics forecasted revenue between $200.00M and $203.00M for the period.

What EPS range did Myriad Genetics (MYGN) guide for?

Myriad Genetics (MYGN) guided EPS in the range of $-0.02 to $0.02 for the fiscal year 2025. The consensus analyst EPS estimate is $-0.16.

What revenue range did Myriad Genetics (MYGN) guide for?

Myriad Genetics (MYGN) guided revenue in the range of $200.00M to $203.00M for Q1 2026.

Did Myriad Genetics (MYGN) raise or lower guidance?

Myriad Genetics (MYGN) lowered its revenue guidance from a prior range of $860.00M - $880.00M to $200.00M - $203.00M for Q1 2026.

When did Myriad Genetics (MYGN) last issue guidance?

Myriad Genetics (MYGN) last issued guidance on February 23, 2026 for Q1 2026.

People Also Watch

Larimar Therapeutics Inc

Armata Pharmaceuticals Inc

AMEX:ARMP

-100.00%

Eupraxia Pharmaceuticals Inc

NASDAQ:EPRX

$7.16

1.78%

Lexeo Therapeutics Inc

NASDAQ:LXEO

$5.51

-4.01%

Century Therapeutics Inc

NASDAQ:IPSC

$2.18

1.16%

Emergent BioSolutions Inc

NYSE:EBS

$8.13

-0.62%

Myriad Genetics (MYGN) last issued guidance on February 23, 2026 for Q1 2026. The company guided revenue in the range of $200.00M - $203.00M for the period.

Compared to prior guidance, Myriad Genetics lowered its revenue forecast from a prior range of $860.00M - $880.00M.

Latest Guidance Date

Feb 23, 2026

Guidance Period

Q1 2026

Revenue Guidance Range

$200.00M - $203.00M

Myriad Genetics Guidance History

Review all historical guidance issued by Myriad Genetics, including EPS and revenue forecasts across quarterly and annual periods.

											Get Alert
02/23/2026	MYGN	Myriad Genetics	Q1	2026	—	—	—	$200.00M	$203.00M	$203.45M	Get Alert
02/23/2026	MYGN	Myriad Genetics	FY	2026	—	—	—	$860.00M	$880.00M	$865.30M	Get Alert
01/12/2026	MYGN	Myriad Genetics	FY	2025	—	—	—	$822.00M	$824.00M	$821.83M	Get Alert
01/12/2026	MYGN	Myriad Genetics	Q4	2025	—	—	—	$207.00M	$209.00M	$207.16M	Get Alert
11/03/2025	MYGN	Myriad Genetics	FY	2025	-$0.02	$0.02	-$0.16	$818.00M	$828.00M	$822.20M	Get Alert
08/05/2025	MYGN	Myriad Genetics	FY	2025	-$0.02	$0.02	-$0.16	$818.00M	$828.00M	$811.32M	Get Alert
05/06/2025	MYGN	Myriad Genetics	FY	2025	-$0.02	$0.02	$0.08	$807.00M	$823.00M	$846.39M	Get Alert
02/24/2025	MYGN	Myriad Genetics	FY	2025	$0.07	$0.11	$0.06	$840.00M	$860.00M	$862.98M	Get Alert
01/15/2025	MYGN	Myriad Genetics	FY	2025	$0.07	$0.11	$0.09	$840.00M	$860.00M	$883.14M	Get Alert
01/15/2025	MYGN	Myriad Genetics	FY	2024	$0.14	$0.15	$0.13	$836.00M	$838.00M	$840.16M	Get Alert
01/15/2025	MYGN	Myriad Genetics	Q4	2024	$0.03	$0.04	$0.03	$209.00M	$211.00M	$212.84M	Get Alert
11/07/2024	MYGN	Myriad Genetics	FY	2024	$0.12	$0.14	$0.10	$837.00M	$843.00M	$841.44M	Get Alert
10/09/2024	MYGN	Myriad Genetics	Q3	2024	—	—	—	$210.00M	$212.00M	$210.39M	Get Alert
10/09/2024	MYGN	Myriad Genetics	FY	2024	—	—	—	$835.00M	$845.00M	$840.81M	Get Alert
08/06/2024	MYGN	Myriad Genetics	FY	2024	$0.08	$0.12	$0.03	$835.00M	$845.00M	$831.73M	Get Alert
05/07/2024	MYGN	Myriad Genetics	FY	2024	$0.00	$0.05	$0.02	$820.00M	$840.00M	$826.58M	Get Alert
02/27/2024	MYGN	Myriad Genetics	FY	2024	$0.00	$0.05	-$0.01	$820.00M	$840.00M	$819.25M	Get Alert
01/16/2024	MYGN	Myriad Genetics	FY	2023	-$0.33	-$0.28	-$0.30	$747.00M	$753.00M	$751.29M	Get Alert
12/21/2023	MYGN	Myriad Genetics	FY	2024	—	—	—	$815.00M	$835.00M	$818.63M	Get Alert
12/21/2023	MYGN	Myriad Genetics	FY	2023	-$0.33	-$0.28	-$0.30	$747.00M	$753.00M	$750.90M	Get Alert
11/06/2023	MYGN	Myriad Genetics	FY	2023	-$0.33	-$0.28	-$0.31	$747.00M	$753.00M	$739.52M	Get Alert
08/03/2023	MYGN	Myriad Genetics	FY	2023	-$0.36	-$0.24	-$0.32	$730.00M	$750.00M	$742.12M	Get Alert
05/03/2023	MYGN	Myriad Genetics	FY	2023	-$0.36	-$0.24	-$0.32	$730.00M	$750.00M	$732.49M	Get Alert
02/28/2023	MYGN	Myriad Genetics	FY	2023	-$0.40	-$0.20	-$0.30	$720.00M	$750.00M	$724.97M	Get Alert
02/28/2023	MYGN	Myriad Genetics	Q1	2023	-$0.20	-$0.18	-$0.10	$170.00M	$172.00M	$174.88M	Get Alert
11/01/2022	MYGN	Myriad Genetics	FY	2022	-$0.35	-$0.30	-$0.06	$668.00M	$672.00M	$692.18M	Get Alert
08/04/2022	MYGN	Myriad Genetics	FY	2022	-$0.10	$0.00	$0.03	$670.00M	$700.00M	$686.67M	Get Alert
05/05/2022	MYGN	Myriad Genetics	FY	2022	$0.00	$0.20	$0.08	$670.00M	$700.00M	$684.40M	Get Alert

Loading calendar...

FAQ

What is the most recent guidance for Myriad Genetics (MYGN)?

The most recent guidance for Myriad Genetics (MYGN) was reported on February 23, 2026 for Q1 2026. Myriad Genetics forecasted revenue between $200.00M and $203.00M for the period.

What EPS range did Myriad Genetics (MYGN) guide for?

Myriad Genetics (MYGN) guided EPS in the range of $-0.02 to $0.02 for the fiscal year 2025. The consensus analyst EPS estimate is $-0.16.

What revenue range did Myriad Genetics (MYGN) guide for?

Myriad Genetics (MYGN) guided revenue in the range of $200.00M to $203.00M for Q1 2026.

Did Myriad Genetics (MYGN) raise or lower guidance?

Myriad Genetics (MYGN) lowered its revenue guidance from a prior range of $860.00M - $880.00M to $200.00M - $203.00M for Q1 2026.

When did Myriad Genetics (MYGN) last issue guidance?

Myriad Genetics (MYGN) last issued guidance on February 23, 2026 for Q1 2026.

People Also Watch

Larimar Therapeutics Inc

Armata Pharmaceuticals Inc

AMEX:ARMP

-100.00%

Eupraxia Pharmaceuticals Inc

NASDAQ:EPRX

$7.16

1.78%

Lexeo Therapeutics Inc

NASDAQ:LXEO

$5.51

-4.01%

Century Therapeutics Inc

NASDAQ:IPSC

$2.18

1.16%

Emergent BioSolutions Inc

NYSE:EBS

$8.13

-0.62%

											Get Alert
02/23/2026	MYGN	Myriad Genetics	Q1	2026	—	—	—	$200.00M	$203.00M	$203.45M	Get Alert
02/23/2026	MYGN	Myriad Genetics	FY	2026	—	—	—	$860.00M	$880.00M	$865.30M	Get Alert
01/12/2026	MYGN	Myriad Genetics	FY	2025	—	—	—	$822.00M	$824.00M	$821.83M	Get Alert
01/12/2026	MYGN	Myriad Genetics	Q4	2025	—	—	—	$207.00M	$209.00M	$207.16M	Get Alert
11/03/2025	MYGN	Myriad Genetics	FY	2025	-$0.02	$0.02	-$0.16	$818.00M	$828.00M	$822.20M	Get Alert
08/05/2025	MYGN	Myriad Genetics	FY	2025	-$0.02	$0.02	-$0.16	$818.00M	$828.00M	$811.32M	Get Alert
05/06/2025	MYGN	Myriad Genetics	FY	2025	-$0.02	$0.02	$0.08	$807.00M	$823.00M	$846.39M	Get Alert
02/24/2025	MYGN	Myriad Genetics	FY	2025	$0.07	$0.11	$0.06	$840.00M	$860.00M	$862.98M	Get Alert
01/15/2025	MYGN	Myriad Genetics	FY	2025	$0.07	$0.11	$0.09	$840.00M	$860.00M	$883.14M	Get Alert
01/15/2025	MYGN	Myriad Genetics	FY	2024	$0.14	$0.15	$0.13	$836.00M	$838.00M	$840.16M	Get Alert
01/15/2025	MYGN	Myriad Genetics	Q4	2024	$0.03	$0.04	$0.03	$209.00M	$211.00M	$212.84M	Get Alert
11/07/2024	MYGN	Myriad Genetics	FY	2024	$0.12	$0.14	$0.10	$837.00M	$843.00M	$841.44M	Get Alert
10/09/2024	MYGN	Myriad Genetics	Q3	2024	—	—	—	$210.00M	$212.00M	$210.39M	Get Alert
10/09/2024	MYGN	Myriad Genetics	FY	2024	—	—	—	$835.00M	$845.00M	$840.81M	Get Alert
08/06/2024	MYGN	Myriad Genetics	FY	2024	$0.08	$0.12	$0.03	$835.00M	$845.00M	$831.73M	Get Alert
05/07/2024	MYGN	Myriad Genetics	FY	2024	$0.00	$0.05	$0.02	$820.00M	$840.00M	$826.58M	Get Alert
02/27/2024	MYGN	Myriad Genetics	FY	2024	$0.00	$0.05	-$0.01	$820.00M	$840.00M	$819.25M	Get Alert
01/16/2024	MYGN	Myriad Genetics	FY	2023	-$0.33	-$0.28	-$0.30	$747.00M	$753.00M	$751.29M	Get Alert
12/21/2023	MYGN	Myriad Genetics	FY	2024	—	—	—	$815.00M	$835.00M	$818.63M	Get Alert
12/21/2023	MYGN	Myriad Genetics	FY	2023	-$0.33	-$0.28	-$0.30	$747.00M	$753.00M	$750.90M	Get Alert
11/06/2023	MYGN	Myriad Genetics	FY	2023	-$0.33	-$0.28	-$0.31	$747.00M	$753.00M	$739.52M	Get Alert
08/03/2023	MYGN	Myriad Genetics	FY	2023	-$0.36	-$0.24	-$0.32	$730.00M	$750.00M	$742.12M	Get Alert
05/03/2023	MYGN	Myriad Genetics	FY	2023	-$0.36	-$0.24	-$0.32	$730.00M	$750.00M	$732.49M	Get Alert
02/28/2023	MYGN	Myriad Genetics	FY	2023	-$0.40	-$0.20	-$0.30	$720.00M	$750.00M	$724.97M	Get Alert
02/28/2023	MYGN	Myriad Genetics	Q1	2023	-$0.20	-$0.18	-$0.10	$170.00M	$172.00M	$174.88M	Get Alert
11/01/2022	MYGN	Myriad Genetics	FY	2022	-$0.35	-$0.30	-$0.06	$668.00M	$672.00M	$692.18M	Get Alert
08/04/2022	MYGN	Myriad Genetics	FY	2022	-$0.10	$0.00	$0.03	$670.00M	$700.00M	$686.67M	Get Alert
05/05/2022	MYGN	Myriad Genetics	FY	2022	$0.00	$0.20	$0.08	$670.00M	$700.00M	$684.40M	Get Alert

Benzinga

Benzinga

Myriad Genetics Inc Stock Guidance

Myriad Genetics Guidance History

FAQ

What is the most recent guidance for Myriad Genetics (MYGN)?

What EPS range did Myriad Genetics (MYGN) guide for?

What revenue range did Myriad Genetics (MYGN) guide for?

Did Myriad Genetics (MYGN) raise or lower guidance?

When did Myriad Genetics (MYGN) last issue guidance?

People Also Watch

Myriad Genetics Guidance History

FAQ

What is the most recent guidance for Myriad Genetics (MYGN)?

What EPS range did Myriad Genetics (MYGN) guide for?

What revenue range did Myriad Genetics (MYGN) guide for?

Did Myriad Genetics (MYGN) raise or lower guidance?

When did Myriad Genetics (MYGN) last issue guidance?

People Also Watch